Final NICE nod for Sanofi’s Gaucher therapy

29th June 2017 Uncategorised 0

Sanofi’s Cerdelga can now be funded on the NHS in England and Wales to treat type 1 Gaucher disease, after cost regulators issued final guidance backing ‘routine’ use of the therapy.

More: Final NICE nod for Sanofi’s Gaucher therapy
Source: News